Learn More
Medchemexpress LLC Larotrectinib | 1223403-58-4 | 99.9% | 10 UMOL

Supplier: Medchemexpress LLC HY1286610MM/1ML
Larotrectinib (LOXO-101) is an ATP-competitive, oral, and selective inhibitor of the tropomyosin-related kinase (TRK) family receptors. It demonstrates low nanomolar 50% inhibitory concentrations against all three isoforms (TRKA, B, and C) and is intended for research use only.
- Inhibitor of TRK family receptors (TRKA, B, and C)
- Exhibits low nanomolar IC50 against TRK isoforms
- For research use only
- Target: Trk Receptor, Apoptosis, Reference Standards
- Pathway: Neuronal Signaling, Protein Tyrosine Kinase/RTK, Apoptosis
- Molecular formula: C21H22F2N6O2
- Molecular weight: 428.44
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.